324 related articles for article (PubMed ID: 28874126)
41. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
[No Abstract] [Full Text] [Related]
42. Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
Li W; Lu H; Wang H; Hu L; Sun X; Yu H; Wang D
Head Neck; 2021 Aug; 43(8):2353-2363. PubMed ID: 33780078
[TBL] [Abstract][Full Text] [Related]
43. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large-population retrospective analysis.
Qu W; Li S; Zhang M; Qiao Q
Cancer Med; 2020 Sep; 9(17):6147-6158. PubMed ID: 32649056
[TBL] [Abstract][Full Text] [Related]
44. Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma.
Jiang Y; Qu S; Pan X; Huang S; Zhu X
Sci Rep; 2020 Jan; 10(1):861. PubMed ID: 31965045
[TBL] [Abstract][Full Text] [Related]
45. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774
[TBL] [Abstract][Full Text] [Related]
46. Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram.
Ding J; Chen J; Lin Y; Hong J; Huang C; Fei Z; Chen C
Braz J Otorhinolaryngol; 2024; 90(2):101363. PubMed ID: 38101121
[TBL] [Abstract][Full Text] [Related]
47. Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas.
Chen Y; Jiang W; Xi D; Chen J; Xu G; Yin W; Chen J; Gu W
J Investig Med; 2019 Mar; 67(3):691-698. PubMed ID: 30127099
[TBL] [Abstract][Full Text] [Related]
48. Impact of magnetic resonance imaging-derived skeletal muscle index in locoregionally advanced nasopharyngeal carcinoma.
Jiang J; Cai Z; Zheng R; Yuan Y; Lv X; Qiu W
Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3707-3715. PubMed ID: 38671169
[TBL] [Abstract][Full Text] [Related]
49. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
50. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
[TBL] [Abstract][Full Text] [Related]
51. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
Cao X; Han Y; He L; Xiang J; Wen Z
Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
[TBL] [Abstract][Full Text] [Related]
52. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
53. Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Xuan W; Chicco A; Fowler A
Radiother Oncol; 2016 Jul; 120(1):87-91. PubMed ID: 27321151
[TBL] [Abstract][Full Text] [Related]
54. Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
Chan SC; Chang JT; Lin CY; Ng SH; Wang HM; Liao CT; Chang CJ; Lin SY; Yen TC
Nucl Med Commun; 2011 Nov; 32(11):989-96. PubMed ID: 21862944
[TBL] [Abstract][Full Text] [Related]
55. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
56. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
[TBL] [Abstract][Full Text] [Related]
57. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
[TBL] [Abstract][Full Text] [Related]
58. Whole-body
Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
[TBL] [Abstract][Full Text] [Related]
59. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
60. Prognostic models for early and late tumor progression prediction in nasopharyngeal carcinoma: An analysis of 8292 endemic cases.
Zhang LL; Zheng WH; Zhu WJ; Deng QL; Peng JL; Li YY; Sun Y; Lin L
Cancer Med; 2023 Mar; 12(5):5384-5396. PubMed ID: 36301691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]